ALB and type 2 diabetes mellitus: Second, the lack of intermediate data on glycemic control, biochemical markers of T2D complications (e.g., urinary albumin-to-creatinine ratio), and changes in the TyG index during the follow-up period restricts insights into the relationship between these variables and outcomes.